Compare GENC & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GENC | VMD |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 254.2M | 351.6M |
| IPO Year | 1995 | 2018 |
| Metric | GENC | VMD |
|---|---|---|
| Price | $17.35 | $9.08 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.50 |
| AVG Volume (30 Days) | 48.7K | ★ 221.5K |
| Earning Date | 08-10-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 8.08 | ★ 32.14 |
| EPS | ★ 0.89 | 0.13 |
| Revenue | $48,943,000.00 | ★ $270,280,000.00 |
| Revenue This Year | $1.78 | $17.63 |
| Revenue Next Year | $25.68 | $11.23 |
| P/E Ratio | ★ $19.49 | $70.46 |
| Revenue Growth | N/A | ★ 20.52 |
| 52 Week Low | $12.22 | $6.05 |
| 52 Week High | $20.19 | $12.61 |
| Indicator | GENC | VMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.76 | 50.85 |
| Support Level | $16.81 | $8.55 |
| Resistance Level | $18.02 | $10.05 |
| Average True Range (ATR) | 0.48 | 0.21 |
| MACD | -0.10 | 0.08 |
| Stochastic Oscillator | 9.88 | 80.17 |
Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.